• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Forte Biosciences, Inc. - Common Stock (NQ:FBRX)

    76.99 UNCHANGED
    Last Price Updated: 4:00 PM EDT, Aug 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 76.99
    Bid (Size) 76.96 (2,700)
    Ask (Size) 77.33 (500)
    Prev. Close 76.99
    Today's Range 76.99 - 76.99
    52wk Range 10.30 - 77.20
    Shares Outstanding 21,051,195
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRX
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    FBRX Stock Alert: Halper Sadeh LLC is Investigating Whether Forte Biosciences, Inc. is Obtaining a Fair Price for its Shareholders
    From Halper Sadeh LLC
    Via Business Wire

    Performance

    52-Week Range 0.3% below 52-week high
    76.99
    10.3052W Low 77.2052W High

    Forte Biosciences, Inc. - Common Stock (FBRX) traded between $10.30 and $77.20 over the past 52 weeks and last traded at $76.99, 0.3% below its 52-week high.

    Past 12 Months
    N/A
    N/A
    +74.5%
    +151.6%
    +226.1%
    +422.0%
    1W  
    1M  
    3M +$32.87
    6M +$46.39
    YTD +$53.38
    1Y +$62.24

    FBRX was +422.0% over the past year, +151.6% over six months, +226.1% year to date.

    12 Months vs Market
    FBRX
    +422.0%
    DIA
    +12.0%
    SPY
    +17.4%
    QQQ
    +24.8%
    IWM
    +14.1%

    Over the past 12 months FBRX returned +422.0% versus DIA (Dow) +12.0%, SPY (S&P 500) +17.4%, QQQ (Nasdaq 100) +24.8% and IWM (Russell 2000) +14.1%.

    Volume & Liquidity
    3M
    1.9M
    6M
    958.8K
    YTD
    671.6K
    1Y
    532.7K

    FBRX's 3-month average daily volume is 1.9M.

    More News

    Read More
    News headline image
    Halper Sadeh LLC is Investigating Whether FBRX, LXFR, SMTI, MKTX are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC is Investigating Whether FBRX and SAFT are Obtaining Fair Deals for their Shareholders
    From Halper Sadeh LLC
    Via GlobeNewswire
    News headline image
    Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRX
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Which stocks are moving on Monday? ↗
    Via Chartmill
    Monday's session: top gainers and losers ↗
    Via Chartmill
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    FBRX Stock Alert: Halper Sadeh LLC is Investigating Whether Forte Biosciences, Inc. is Obtaining a Fair Price for its Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    These stocks that are showing activity before the opening bell on Monday. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline
    From Forte Biosciences, Inc.
    Via Business Wire
    Top movers analysis one hour before the close of the markets on 2026-07-10: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    Forte Biosciences' FB102 Hits Key Goal in Vitiligo Study, Shows Durable Improvement ↗
    Via MarketBeat
    Which stocks are experiencing notable movement on Thursday? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's Intraday Session ↗
    Via Benzinga
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    News headline image
    FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 After Completion of 12-Week Treatment Period
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences, Inc. Announces First Quarter 2026 Results and Provides Update
    From Forte Biosciences, Inc.
    Via Business Wire
    Which stocks are experiencing notable movement on Thursday? ↗
    Via Chartmill
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    News headline image
    Forte Biosciences Announces Pricing of $150 Million Public Offering
    From Forte Biosciences, Inc.
    Via Business Wire
    News headline image
    Forte Biosciences Announces Proposed Public Offering
    From Forte Biosciences, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Forte Biosciences, Inc. - Common Stock publicly traded?
    Yes, Forte Biosciences, Inc. - Common Stock is publicly traded.
    What exchange does Forte Biosciences, Inc. - Common Stock trade on?
    Forte Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Forte Biosciences, Inc. - Common Stock?
    The ticker symbol for Forte Biosciences, Inc. - Common Stock is FBRX on the Nasdaq Stock Market
    What is the current price of Forte Biosciences, Inc. - Common Stock?
    The current price of Forte Biosciences, Inc. - Common Stock is 76.99
    When was Forte Biosciences, Inc. - Common Stock last traded?
    The last trade of Forte Biosciences, Inc. - Common Stock was at 08/26/26 04:00 PM ET
    What is the market capitalization of Forte Biosciences, Inc. - Common Stock?
    The market capitalization of Forte Biosciences, Inc. - Common Stock is 1.62B
    How many shares of Forte Biosciences, Inc. - Common Stock are outstanding?
    Forte Biosciences, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.